These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma. Im HJ; Kim TS; Park SY; Min HS; Kim JH; Kang HG; Park SE; Kwon MM; Yoon JH; Park HJ; Kim SK; Park BK Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):39-49. PubMed ID: 21953008 [TBL] [Abstract][Full Text] [Related]
5. Staging canine patients with appendicular osteosarcoma utilizing fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography compared to whole body computed tomography. Brody A; Crooks JC; French JM; Lang LG; Randall EK; Griffin LR Vet Comp Oncol; 2022 Sep; 20(3):541-550. PubMed ID: 35166445 [TBL] [Abstract][Full Text] [Related]
6. Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma. Lee I; Byun BH; Lim I; Kim BI; Kong CB; Song WS; Cho WH; Koh JS; Lim SM Medicine (Baltimore); 2018 Sep; 97(37):e12318. PubMed ID: 30212975 [TBL] [Abstract][Full Text] [Related]
7. The use of fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography as an effective method for staging in dogs with primary appendicular osteosarcoma. Crooks C; Randall E; Griffin L Vet Radiol Ultrasound; 2021 May; 62(3):350-359. PubMed ID: 33629412 [TBL] [Abstract][Full Text] [Related]
9. Can pretreatment Song H; Jiao Y; Wei W; Ren X; Shen C; Qiu Z; Yang Q; Wang Q; Luo QY Eur Radiol; 2019 Jul; 29(7):3945-3954. PubMed ID: 30859285 [TBL] [Abstract][Full Text] [Related]
10. Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma. Hurley C; McCarville MB; Shulkin BL; Mao S; Wu J; Navid F; Daw NC; Pappo AS; Bishop MW Pediatr Blood Cancer; 2016 Aug; 63(8):1381-6. PubMed ID: 27082077 [TBL] [Abstract][Full Text] [Related]
11. Prospective pilot study utilizing changes in quantitative values obtained on serial fluorine-18 fluorodeoxyglucose ( Martin TW; Griffin L Vet Radiol Ultrasound; 2024 Jul; 65(4):408-416. PubMed ID: 38655687 [TBL] [Abstract][Full Text] [Related]
12. Utilization of positron emission tomography in the management of patients with sarcoma. Benz MR; Tchekmedyian N; Eilber FC; Federman N; Czernin J; Tap WD Curr Opin Oncol; 2009 Jul; 21(4):345-51. PubMed ID: 19412096 [TBL] [Abstract][Full Text] [Related]
13. Response of osteogenic sarcoma to neoadjuvant therapy: evaluated by 18F-FDG-PET. Ye Z; Zhu J; Tian M; Zhang H; Zhan H; Zhao C; Yang D; Li W; Lin N Ann Nucl Med; 2008 Jul; 22(6):475-80. PubMed ID: 18670853 [TBL] [Abstract][Full Text] [Related]
15. Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI. Byun BH; Kong CB; Lim I; Kim BI; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1553-62. PubMed ID: 24652233 [TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. Völker T; Denecke T; Steffen I; Misch D; Schönberger S; Plotkin M; Ruf J; Furth C; Stöver B; Hautzel H; Henze G; Amthauer H J Clin Oncol; 2007 Dec; 25(34):5435-41. PubMed ID: 18048826 [TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT in a rare malignant extraskeletal osteosarcoma. Cao Q; Lu M; Huebner T; Dilsizian V; Chen W Clin Nucl Med; 2013 Sep; 38(9):e367-9. PubMed ID: 23856822 [TBL] [Abstract][Full Text] [Related]
18. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis. Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700 [TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. Costelloe CM; Macapinlac HA; Madewell JE; Fitzgerald NE; Mawlawi OR; Rohren EM; Raymond AK; Lewis VO; Anderson PM; Bassett RL; Harrell RK; Marom EM J Nucl Med; 2009 Mar; 50(3):340-7. PubMed ID: 19258257 [TBL] [Abstract][Full Text] [Related]
20. The role of Angelini A; Ceci F; Castellucci P; Graziani T; Polverari G; Trovarelli G; Palmerini E; Ferrari S; Fanti S; Ruggieri P Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1712-1720. PubMed ID: 28405727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]